PATENT CLAIM ANALYSIS

Application Number: 15914016
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "210210"]

Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 2):
A compound of  claim 1 , wherein the compound is one of an enantimor selected from the following:

Metadata:
- Claim Count in Document: 14.0
- Percentile: 90.0
- Lexical Diversity: 1.63265
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15216119', '15863216', '10400387', '13905410', '15645701']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7753491557500284
- 35 USC 102 Novelty (BERT): 0.5499849036594662
- Combined Prediction Score: 0.7528127305409722
- Mean Citation Score: 335.19447599999995
- Max Citation Score: 406.19183
- Similarity Product: 252.6166881225312

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test